BSE Live
Jan 16, 11:36Prev. Close
69.21
Open Price
69.00
Bid Price (Qty.)
68.82 (57)
Offer Price (Qty.)
69.30 (210)
NSE Live
Jan 16, 11:36Prev. Close
69.23
Open Price
69.99
Bid Price (Qty.)
69.02 (6)
Offer Price (Qty.)
69.17 (6)
| Balance Sheet of Brooks Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 16.19 | 16.19 | 16.19 | 16.19 | 9.89 | |
| Total Share Capital | 16.19 | 16.19 | 16.19 | 16.19 | 9.89 | |
| Reserves and Surplus | 95.23 | 96.10 | 89.22 | 75.08 | 9.54 | |
| Total Reserves and Surplus | 95.23 | 96.10 | 89.22 | 75.08 | 9.54 | |
| Total Shareholders Funds | 111.42 | 112.29 | 105.41 | 91.26 | 19.43 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.90 | |
| Deferred Tax Liabilities [Net] | 1.33 | 1.60 | 1.38 | 1.21 | 1.02 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.66 | 0.61 | 0.56 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 1.99 | 2.20 | 1.94 | 1.21 | 1.92 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.51 | 0.14 | 1.09 | 0.00 | 7.76 | |
| Trade Payables | 19.07 | 12.30 | 12.85 | 7.24 | 7.01 | |
| Other Current Liabilities | 1.78 | 4.49 | 3.13 | 1.16 | 0.73 | |
| Short Term Provisions | 0.38 | 9.02 | 7.24 | 4.93 | 4.01 | |
| Total Current Liabilities | 21.74 | 25.94 | 24.32 | 13.33 | 19.52 | |
| Total Capital And Liabilities | 135.14 | 140.44 | 131.66 | 105.80 | 40.86 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 15.68 | 20.15 | 20.65 | 26.73 | 19.09 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 53.50 | 37.16 | 35.52 | 15.30 | 0.63 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 69.18 | 57.31 | 56.17 | 42.03 | 19.72 | |
| Non-Current Investments | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 11.16 | 10.14 | 6.25 | 19.90 | 3.79 | |
| Other Non-Current Assets | 0.00 | 3.29 | 3.29 | 3.27 | 0.43 | |
| Total Non-Current Assets | 80.36 | 70.76 | 65.72 | 65.22 | 23.96 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 7.53 | 6.03 | 4.98 | 5.16 | 5.50 | |
| Trade Receivables | 19.29 | 16.46 | 21.68 | 10.76 | 6.96 | |
| Cash And Cash Equivalents | 22.92 | 29.99 | 23.87 | 18.68 | 0.87 | |
| Short Term Loans And Advances | 3.56 | 0.74 | 0.41 | 5.98 | 3.57 | |
| OtherCurrentAssets | 1.47 | 16.46 | 15.00 | 0.00 | 0.00 | |
| Total Current Assets | 54.78 | 69.68 | 65.94 | 40.58 | 16.91 | |
| Total Assets | 135.14 | 140.44 | 131.66 | 105.80 | 40.86 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 79.99 | 66.29 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 13.17 | 13.57 | 11.54 | 9.29 | 9.91 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.11 | 0.00 | 0.00 | 32.71 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 11.41 | 0.13 | 0.00 | 0.02 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 9.12 | 9.12 | 9.12 | 9.12 | 5.15 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
04.12.2025
Brooks Labs Consolidated September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
27.11.2025
Brooks Labs Standalone September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
04.12.2025
Brooks Labs Consolidated September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
27.11.2025
Brooks Labs Standalone September 2025 Net Sales at Rs 23.45 crore, up 12.79% Y-o-Y
12.06.2025
Brooks Labs Standalone March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y
05.06.2025
Brooks Labs Consolidated March 2025 Net Sales at Rs 23.32 crore, up 31.57% Y-o-Y